U.S. Software Stock News

Urban Outfitters (URBN) has been removed from the Russell 2000 Dynamic Index, a shift that can influence how index-tracking funds treat the stock and potentially affect short term trading flows. See our latest analysis for Urban Outfitters. At a share price of US$70.86, Urban Outfitters has seen short term share price pressure, with the 30 day share price return down 2.46%, while the 90 day share price return is up 11.21% and the 3 year total shareholder return is 110.14%. This points to...

Matson (MATX) has been drawing investor attention after a strong share price move, with the stock up about 6% over the past month and about 16% in the past 3 months. See our latest analysis for Matson. At around $192 per share, Matson’s recent 6% 1 month share price return and 16.6% 3 month share price return sit on top of a much stronger backdrop, with a 55.4% year to date share price return and 69.8% 1 year total shareholder return pointing to momentum that has been building rather than...

Interest rate headlines are back in focus as the Federal Reserve signals a possible pause or slowdown in hikes, and that matters for rate sensitive areas like Real Estate and Utilities. With mixed economic data and a cautious central bank, some stocks in these sectors may see sentiment shift as investors rethink income, value, and balance sheet risk. This article looks at 3 stocks from a Rate Sensitive Sectors screener that appear positively exposed to the current Fed stance. It is intended...

Following a 23% one day jump after its latest earnings release, Twilio (TWLO) has seen its share price cool, creating fresh interest among investors who are assessing whether this reset offers a more measured entry. See our latest analysis for Twilio. That sharp earnings gap and subsequent cool off sit within a wider upswing for Twilio, with a 90 day share price return of 58.16% and a 1 year total shareholder return of 76.00%. This indicates momentum that has recently been strong rather than...

In late June 2026, CareTrust REIT, Inc. (NYSE: CTRE) was removed from multiple Russell growth and small-cap indexes, shortly after its Board reaffirmed a quarterly cash dividend of US$0.39 per share payable in mid-July to shareholders of record on June 30, 2026. This combination of index deletions and steady dividend payments highlights a tension between potential index-related selling pressure and the company’s ongoing income profile for shareholders. Against this backdrop, we will examine...

In late June 2026, Loar Holdings Inc. (NYSE: LOAR) was removed from several Russell growth indices, including the Russell 1000 Growth, Russell 3000 Growth, Russell 3000E Growth, Russell Midcap Growth, and Russell 2500 Growth benchmarks, prompting benchmark-driven portfolio rebalancing. This broad index removal contrasts with ongoing positive analyst views and hedge fund interest, highlighting how benchmark membership can materially influence investor demand and company visibility. Next,...

Cytokinetics reported progress in turning its lead heart drug Myqorzo from a development program into an early commercial product, supported by prior regulatory approvals in the US, Europe, and China. Early physician adoption and patient response, together with Myqorzo’s differentiated mechanism in obstructive hypertrophic cardiomyopathy, are sharpening expectations around its broader clinical and competitive role. Next, we’ll look at how Myqorzo’s early commercial uptake and multi-region...

Whirlpool stock performance snapshot Whirlpool (WHR) stock has been under pressure recently, with the share price around $39.42 and total returns declining over the past month, past 3 months, year to date, and the past 1 year. See our latest analysis for Whirlpool. For Whirlpool, the recent 1 week share price return of 8.93% comes after a tougher stretch, with the 30 day share price return down 9.21% and the 1 year total shareholder return down 61.20%. This suggests recent momentum is...

Viridian Therapeutics (VRDN) is in focus after the U.S. Food and Drug Administration approved Lumvoa for thyroid eye disease, covering both active and chronic forms. The stock moved 6% higher after hours. See our latest analysis for Viridian Therapeutics. Viridian Therapeutics’ latest FDA approval comes after a mixed stretch for holders, with the share price down 40.11% year to date but a 1 year total shareholder return of 26.99%. This suggests sentiment has shifted recently as new catalysts...

Drone defense sits at the crossroads of national security, energy driven inflation stories, and shifting government budgets, yet not every stock in this area is built to handle long procurement cycles or rising funding costs. With inflation trends diverging across regions and bond yields and currencies moving on central bank signals, many investors are focusing on companies with strong balance sheets and solid cash cushions. This Financially Strong Drone Defense Stocks screener filters for...

In late June 2026, Arcutis Biotherapeutics announced FDA approval to extend ZORYVE cream 0.3% plaque psoriasis treatment to children aged 2–5, alongside launching a virtual health platform that connects eczema, seborrheic dermatitis, and plaque psoriasis patients with independent dermatologists for streamlined access to care. This combination of a broader pediatric indication and a company-backed but physician-directed digital access channel could meaningfully influence how ZORYVE reaches...

Aon (AON) has come under focus after being removed from several Russell growth indices. This shift can influence passive fund flows, investor perception, and how growth-focused portfolios treat the stock. See our latest analysis for Aon. Following the Russell growth index removals, Aon’s recent momentum has been mixed, with a 7 day share price return of 3.41% and a year to date share price return that is down 3.65%, alongside a 5 year total shareholder return of 45.21%. If you are reassessing...

Associated Banc-Corp recently announced that Andy Miner has joined as senior director, AI for Corporate & Commercial Banking, where he will lead AI strategy, use cases, delivery, adoption, and oversight of risk and data for the business. By appointing a dedicated AI leader with experience scaling analytics teams at U.S. Bank and Target, Associated is signaling a deeper push to embed data-driven decision-making into its commercial banking operations. Next, we’ll examine how Miner's...

On 27 June 2026, NPK International Inc. (NYSE:NPKI) was reclassified across the Russell index family, joining several growth-focused benchmarks while exiting a range of value-oriented indexes, including the Russell 2000 Value and Russell 3000 Value benchmarks. This broad shift from value to growth classifications signals that index providers now see NPK International’s profile as more aligned with growth characteristics, which can influence how both passive and active investors categorize...

DigitalOcean Holdings (DOCN) is back in focus after a broad reshuffle in the Russell index family, with the stock exiting the Russell 2000 series and entering several Russell 1000 and Midcap benchmarks. See our latest analysis for DigitalOcean Holdings. At a latest share price of $157.03, DigitalOcean Holdings has seen strong momentum build over the past quarter with a 90 day share price return of 79.09%. The 1 year total shareholder return of 460.42% and 5 year total shareholder return of...

Why Paychex dropping from growth indexes matters after strong results Paychex (PAYX) is in focus after solid full year 2026 earnings and fresh 2027 guidance were followed by its removal from several Russell growth benchmarks. This combination raises practical questions for stockholders. The company reported full year revenue of US$6.5b and net income of US$1.8b, alongside a completed US$686 million buyback program, while also being dropped from indexes such as the Russell 1000 Growth and...

Why Arlo Technologies Stock Is Back in Focus Arlo Technologies (ARLO) is drawing fresh attention after announcing an expanded partnership that brings Aloe Care Health’s new ConnectAI wellness calling solution into Home Helpers Home Care’s in-home care offerings for aging clients. The move deepens Arlo Technologies’ role in AI-powered, connected care by linking smart home capabilities with proactive wellness check-ins, medication reminders, and care insights for people who want to remain...

Why F5 Stock Is Back in Focus After AI Security Moves and Market Tailwinds F5 (FFIV) is drawing fresh attention after launching its new AI Security Platform, acquiring SurePath AI, and expanding its Equinix partnership, alongside a broader tech rebound following US Iran de escalation. See our latest analysis for F5. Those AI security announcements and the Equinix partnership have arrived while momentum in F5 stock has been strong, with a 38.9% 90 day share price return and a 180.9% three...

On 27 June 2026, Babcock & Wilcox Enterprises (NYSE: BW) was added to a broad suite of Russell indices, including the Russell 2000, 2500 and 3000 families, spanning both growth and value benchmarks as well as small-cap completeness measures. This unusually wide inclusion across multiple Russell indices can increase the company’s visibility with institutional investors and index-tracking funds that reference these benchmarks. Next, we’ll examine how Babcock & Wilcox’s broad inclusion across...

What SiTime’s Index Moves Mean for Investors SiTime (SITM) has shifted into a new tier of equity benchmarks, joining the Russell 1000, Russell Midcap, and related growth and dynamic indexes while exiting several Russell 2000 variants. For you as an investor, these index changes matter because funds that track the Russell 1000, Russell Midcap, and associated growth benchmarks often adjust their holdings to match the new compositions. That process can influence trading activity in SiTime stock...

In late June 2026, Olema Pharmaceuticals, Inc. (NasdaqGS:OLMA) was added to multiple Russell Growth Benchmarks, including the Russell 2000, 2500, 3000, 3000E, Small Cap Comp, and Microcap Growth indices. This broad index inclusion brings Olema onto the radar of a wide range of index-tracking funds and quantitative investors, potentially changing how the company is positioned in many portfolios. Next, we will examine how Olema’s broad Russell Growth index inclusion shapes its investment...

Defense and aerospace stocks are back in focus after AeroVironment surprised the market, with its shares jumping 21% on revenue that doubled year over year and a funded backlog reaching $1.2b. That move, combined with a record US$75b drone request within a proposed US$1.5t U.S. defense budget for 2027, has drawn attention to companies linked to drones, autonomous systems, and broader military technology. If you are looking for ideas on which stocks could be potential beneficiaries or ones to...

In late June 2026, DENTSPLY SIRONA Inc. was removed from several major Russell benchmarks, including the Russell 1000 and Russell Midcap indexes, and simultaneously added to the Russell 2000, Russell 2000 Value, and Russell 2000 Dynamic indexes, while also filing a US$161.7 million shelf registration related to 15,000,000 common shares for an ESOP offering. This reshuffling shifts DENTSPLY SIRONA’s index footprint from large- and mid-cap toward smaller-cap benchmarks, potentially altering...

In late June 2026, Preformed Line Products Company was removed from multiple Russell value and small-cap benchmark indices, following an earlier affirmation of its regular US$0.21 per-share quarterly dividend payable on July 20, 2026. This wave of index deletions matters because it can trigger mechanical selling by index-tracking funds, potentially altering the stock’s investor base and liquidity profile. Next, we’ll examine how the extensive Russell index removals shape Preformed Line...